expert perspectives

in Systemic Lupus Erythematosus

Expert Perspectives in Systemic Lupus Erythematosus to Cover Key Topics in Systemic Lupus Erythematosus Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Systemic Lupus Erythematosus will feature selected topics in Systemic Lupus Erythematosus that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Bevra H. Hahn, MD

Professor of Medicine, Emeritus
Rheumatologist
UCLA School of Medicine
Los Angeles, CA

Joan T. Merrill, MD

Member and Director of Clinical Projects
Arthritis & Clinical Immunology Research Program
Oklahoma Medical Research Foundation
OMRF Professor of Medicine
University of Oklahoma Health Sciences Center
Adjunct Professor of Medicine
New York University Langone Health
Chief Advisor for Clinical Development
Lupus Foundation of America
Oklahoma City, OK

George C. Tsokos, MD

Professor of Medicine
Harvard Medical School
Chief, Division of Rheumatology and Clinical Immunology
Beth Israel Deaconess Medical Center
Boston, MA


Community-Selected Topics:

Expert Roundtables 

    Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
    Targeted Biologic Therapy in Systemic Lupus Erythematosus
    Improving Long-term Outcomes in Systemic Lupus Erythematosus: Trends and Contributors
    The Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: Preventing Early Damage

Clinical Topic Updates 

    Systemic Lupus Erythematosus: Treatments in Development
    Interferon-Blocking Strategies in Systemic Lupus Erythematosus Research
    Genetic Susceptibility to Common and Severe Manifestations of Systemic Lupus Erythematosus
    Research on Drug-Induced Systemic Lupus Erythematosus Sheds Light on Autoimmunity

Patient Care Perspectives 

    Low-Dose Interleukin 2 and Its Potential in Systemic Lupus Erythematosus
    Impact of COVID-19 in Systemic Lupus Erythematosus
    Outcomes With B-Cell Activating Factor Inhibition in the Real-World Setting
    Emerging Therapeutic Targets in Systemic Lupus Erythematosus: Treatment and Maintenance

More in Systemic Lupus Erythematosus

Thumb

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: Treatments in Development

Clinical Topic Updates by Bevra H. Hahn, MD

Recent data with belimumab and voclosporin are of interest in the setting of lupus nephritis, a common complication in patients with systemic lupus...READ MORE

Thumb

Systemic Lupus Erythematosus

Impact of COVID-19 on Systemic Lupus Erythematosus

Patient Care Perspectives by George C. Tsokos, MD

Patients with systemic lupus erythematosus (SLE) may be more vulnerable to infections due to factors related to both the SLE and its treatment. Gui...READ MORE

Thumb

Systemic Lupus Erythematosus

Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

Expert Roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Despite significant advances in the understanding of the pathophysiology of systemic lupus erythematosus (SLE), a number of challenges persist. In ...READ MORE

More In Rheumatology

Systemic Lupus Erythematosus

Can Research On Drug Induced Lupus Erythematosus Shed Light On Autoimmunity?

Clinical Topic Updates by George C. Tsokos, MD

Systemic Lupus Erythematosus

Genetic Susceptibility To Common And Severe Manifestations Of Systemic Lupus Erythematosus

Clinical Topic Updates by Joan T. Merrill, MD

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: Outcomes With B Cell Inhibition In The Real World Setting

Patient Care Perspectives by Bevra H. Hahn, MD